Meet the Team

Professor Graham Cookson is Director Designate at the Office of Health Economics, and will take over the role of Director from Professor Adrian Towse on 1st January 2019.

Graham is an econometrician by training and is interested in the use of big data in health and life sciences research. His current research interests include the measurement and determinants of productivity in healthcare especially labour productivity; the industrial organisation of healthcare especially tariffs and competition; real-world evidence in health economic evaluation; and big data in the health and life sciences. He is best known for this work on the economics of staffing and skill mix in the English NHS, and this research was critical to the development of the NICE Guidelines on Safe Staffing.

Nancy's principal areas of research expertise are the measurement and valuation of patient reported health outcomes; the cost effectiveness thresholds used in making judgments about value for money in health care; use of MCDA in health care decision making; priority setting in health care; and measuring the production, performance and efficiency of hospitals.

Amanda’s current research interests include the use of real world evidence to support HTA and product development; novel pricing and reimbursement mechanisms for pharmaceuticals (e.g. managed entry agreements and the economics of indication-based pricing); health state valuation methodology; criteria for the economic evaluation of health interventions; and the interaction between HTA policy and optimal R&D decisions by industry

Martina’s current research includes economic issues posed by the development and provision of treatments for rare diseases; the economics of personalised medicine for health care payers and the pharmaceutical industry; and approaches to value based assessments.

Grace’s areas of expertise include health technology appraisal, economic modelling and clinical guidelines. Grace is also interested in the economic evaluation of diagnostics and patient stratification, early stage modelling, and the economic evaluation of regenerative medicines and other high cost therapies. Grace has recently been appointed to NICE’s Clinical Guidelines Update Standing Committee, where she provides expert advice on the economic implications of NICE’s clinical guideline recommendations.

Margherita joined the OHE in December 2016 as Economist. Her work at the OHE has involved a number consulting projects, relating to different aspects of pharmaceutical R&D and HTA activities. She has experience in supporting the development of internal strategies for pharmaceutical companies in defining the value proposition of their pipeline (e.g. value frameworks) and the evidence generation processes during the product lifecycle.

Marina’s research interests focus on the evaluation of healthcare programmes’ effectiveness, focusing on quality of life factors that impact budgets and decision making. She is also interested in the economics of health care systems in emerging markets.

Chris’s primary research interest is economic evaluation in health care, including the development of new methods for cost-effectiveness analysis and the valuation of health. He has worked on trial- and model-based economic evaluations in a variety of clinical fields. Chris is also dedicated to building new platforms for collaboration in the discipline of health economics.

Kerry's responsibilities include maintaining the website, overseeing the production and publishing of in-house publications, organising events and serving as the contact point for accounts. Before joining the OHE in 2000, she was with the ABPI.